In short
- A peptide is a short chain of amino acids. Under an FDA rule from February 2020, a chain of more than 40 amino acids counts as a protein, and proteins are regulated as biologics.
- Several FDA-approved drugs are peptides, including the GLP-1 medicines and Vyleesi (bremelanotide); tesamorelin (Egrifta SV) is regulated as a biologic.
- As of October 18, 2026, a licensed pharmacy may compound sermorelin, PT-141, oxytocin and topical GHK-Cu for an individual prescription; BPC-157, TB-500 and most others still can’t be compounded.
- Online, these peptides cost $89 to $330 a month depending on the peptide and provider, taking each provider’s lowest ongoing price with any membership included.
- Peptides sold ‘for research use only’ come with no prescriber, no pharmacy and no FDA review behind them.
Peptides are short chains of amino acids, the same building blocks that make up proteins. Your body makes many of them, and some act as signals: oxytocin and the gut hormone GLP-1 both work this way. As medicines, peptides range from FDA-approved drugs such as the GLP-1 weight-loss injections, to compounded prescriptions such as sermorelin, to “research chemicals” sold online with no prescription and no pharmacy behind them.
That range is why the word causes so much confusion. Here is what a peptide is, how the FDA sorts them, which ones you can get lawfully, and what they cost.
Peptide or protein: where the line is
Both peptides and proteins are chains of amino acids; the difference is length. In a final rule published on February 21, 2020, the FDA defined a protein as any chain of amino acids with a specific, defined sequence that is greater than 40 amino acids in size. Proteins are regulated as biological products. Chains of 40 or fewer are peptides, which are regulated as drugs.
That line has practical consequences. On March 23, 2020, the FDA moved a group of older drugs, including insulin, hCG and tesamorelin, from drug approvals to biologics licenses (FDA list). Because pharmacy compounding under section 503A covers drugs, not biologics, a pharmacy can’t compound tesamorelin; only brand-name Egrifta SV can be prescribed.
The three kinds of peptide you will see online
Scroll sideways to see the full table
| Kind | Examples | Prescription? | FDA-reviewed? |
|---|---|---|---|
| FDA-approved peptide drugs | Wegovy and Zepbound (GLP-1s), Vyleesi (bremelanotide), Egrifta SV (tesamorelin), oxytocin injection | Yes | Yes, for the approved uses |
| Compounded peptides | Sermorelin, PT-141, oxytocin nasal spray or troche, topical GHK-Cu | Yes, from a 503A pharmacy | No |
| Gray-market “research” peptides (unsafe, unregulated) | BPC-157, TB-500, MOTS-c, CJC-1295, ipamorelin | Sold without one | No |
FDA-approved peptides went through clinical trials and FDA review for a specific use. The GLP-1 medicines for weight loss and diabetes are the best-known examples. Vyleesi (bremelanotide) is approved for low sexual desire in premenopausal women, and Egrifta SV (tesamorelin) to reduce belly fat in adults with HIV-related lipodystrophy.
Compounded peptides are prepared by a state-licensed pharmacy for one patient’s prescription. They aren’t FDA-approved, and the FDA doesn’t review them for safety, effectiveness or quality before they’re sold. A pharmacy may compound a peptide only if the ingredient qualifies: it is part of an FDA-approved drug, has a USP monograph, appears on the FDA’s 503A bulks list, or, under an interim policy, sits in Category 1 of the FDA’s nominations list.
Research-use peptides are sold labeled “not for human consumption.” Selling them for people to inject isn’t legal, and no prescriber or pharmacy stands behind what is in the vial. Our guide to whether peptides are safe covers what the FDA has found.
Which peptides a pharmacy may compound in 2026
As of October 18, 2026, using the FDA’s categories list updated May 14, 2026:
| Peptide | What it’s prescribed for | Compounding status |
|---|---|---|
| Sermorelin | Raising your own growth hormone (off-label for adults) | Allowed: it is the ingredient in Geref, an approved drug its maker discontinued in 2008, not for safety reasons |
| PT-141 (bremelanotide) | Sexual desire | Allowed: it is the ingredient in Vyleesi, as long as the compounded product isn’t essentially a copy of Vyleesi made regularly or in large amounts; use in men is off-label |
| Oxytocin | Stress, mood, sleep or intimacy (all off-label) | Allowed as sprays or troches: it is the ingredient in an approved injection |
| GHK-Cu, topical | Skin and scalp | Allowed for non-injectable forms (Category 1) |
| GHK-Cu, injectable | Marketed for healing and skin | Not allowed: in no category |
| BPC-157, TB-500, MOTS-c, KPV | Healing, recovery, energy | Not allowed: in no category |
| CJC-1295, ipamorelin | Growth hormone | Not allowed |
The list changes. In April 2026, the FDA moved nine peptides, including BPC-157 and TB-500, off its list of substances with significant safety risks after their nominations were withdrawn, and in July 2026 an advisory committee voted on seven of them. Neither step made them legal to compound. The full timeline is in are peptides legal in 2026, and BPC-157 has its own guide: BPC-157: uses, evidence and legal status.
What the evidence shows
Evidence depends on the peptide, and for most compounded uses it is thin.
- Bremelanotide. In two 24-week trials of premenopausal women with low desire, the desire score rose 0.5 and 0.6 points on Vyleesi against 0.2 on placebo, while the number of satisfying sexual events didn’t differ from placebo. The FDA hasn’t reviewed any trial in men.
- Tesamorelin. In two 26-week trials of adults with HIV and lipodystrophy, belly fat fell 18% and 14% on tesamorelin, against a 2% rise and a 2% fall on placebo. Its label says it isn’t for weight loss.
- Oxytocin. The approved injection was studied only for labor and delivery. The FDA hasn’t reviewed any trial of compounded oxytocin for stress, mood, sleep or sexual function.
- GHK-Cu. A 2018 review by researchers who study the peptide reports a 12-week cream study in 71 women with sun-aged skin that improved skin density and fine lines. No large controlled trial exists.
- Sermorelin. Its old Geref labeling covered children, not adults using it for aging. The trials in older adults are small and short: in 11 men aged 64 to 76, six weeks raised growth hormone release and improved 2 of 6 strength measures without changing muscle or fat, and no trial has tested it for aging outcomes.
If a site promises that a peptide will heal injuries, burn fat or reverse aging, that claim has not been through FDA review.
Safety basics
Peptides are biologically active, and side effects depend on the peptide. Bremelanotide briefly raises blood pressure after each dose (by up to 6/3 mmHg in its trials) and commonly causes nausea, so it isn’t for people with uncontrolled high blood pressure or heart disease. Oxytocin makes the uterus contract, so it isn’t for use in pregnancy outside a hospital. Injected products carry the risks of any injection, and those risks rise sharply when nobody knows what is in the vial or how it was made.
The safest route is the lawful one: a licensed clinician who reviews your health first, and a named, licensed pharmacy that prepares the medicine. Ask which pharmacy will fill your prescription, and check its license with your state board of pharmacy.
What peptides cost online
Licensed online providers prescribe the four compoundable peptides after a clinician review. As of October 2026, taking each provider’s lowest ongoing monthly price with medication and any required membership included:
| Peptide | Monthly price range | Compare |
|---|---|---|
| Sermorelin | $99 to $330 | Best sermorelin providers |
| PT-141 | $129 to $280 | PT-141 providers |
| Oxytocin | $121 to $220 | Peptide providers |
| Topical GHK-Cu | $89 to $167 | GHK-Cu cream providers |
Insurance rarely covers compounded peptides. For a breakdown of memberships and lab fees, see do peptides need a prescription and the sermorelin cost guide. Every provider we compare is on the peptides hub.
The bottom line
A peptide is a chain of 40 or fewer amino acids; longer chains are proteins and are regulated as biologics. Some peptides are FDA-approved drugs, four can be compounded by a licensed pharmacy for your prescription, and most of the peptides marketed online, including BPC-157 and TB-500, can’t be lawfully compounded at all. Evidence for compounded uses is limited, so start with a licensed clinician and a named pharmacy, and treat “research use only” as the warning it is.
Questions, answered
What is the difference between a peptide and a protein?
Are peptides steroids?
Do peptides need a prescription?
Which peptides are legal to buy online?
Sources
- Federal Register: Definition of the term “biological product” (FDA final rule, Feb 21, 2020)
- FDA: List of approved NDAs for biological products deemed to be BLAs on Mar 23, 2020
- FDA: Bulk drug substances nominated for use in compounding under section 503A (categories list, updated May 14, 2026)
- FDA: Interim policy on compounding using bulk drug substances under section 503A (Jan 7, 2025)
- Vyleesi (bremelanotide) prescribing information, DailyMed
- Egrifta SV (tesamorelin) prescribing information, DailyMed
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci. 2018;19(7):1987